20mg transdermal selegiline daily may be effective and well tolerated in adults with major depression: Commentary

Evidence-Based Mental Health

Volumn 6, Issue 2, 2003, Pages 44-

  Benedictis, Eliana ^a  

^a PAREXEL INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4644248889     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.6.2.44     Document Type: Note

References (4)

1. Robinson DS. Monoamine oxidase inhibitors: a new generation. Psychopharm Bull 2002; 36: 124-38.
2. Bodkin JA, Kwon AE. Selegiline and other atypical MAO inhibitors in depression. Ann Psych 2001; 31: 385-91.
3. Azzaro AJ, Blob LF, Kemper EM et al. Pressor effects of oral tyramine and over-the-counter (OTC) sympathomimetic amines following steady-state transdermal administration of selegiline to healthy volunteers. In: Scientific Abstracts of the 2000 Annual Meeting of the American College of Neuropsychopharmacology. Nashville: 2000: 268.
4. Murphy M, Carmichael AJ. Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management. Am J Clin Dermatol 2000; 1: 361-8.